@article {344, title = {Perception of Pharmacists About the High-Risk/Alert Medications in Saudi Arabia}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {December 2022}, pages = {151-160}, type = {Research Article }, chapter = {151}, abstract = {

Objectives: To demonstrate the perception of pharmacists about the High-Risk/ Alert medications in Saudi Arabia. Methods: It analyzes a cross-sectional survey that discussed the perception of pharmacists about High-Risk/Alert medications in Saudi Arabia. The survey consisted of respondents{\textquoteright} demographic information about pharmacists and The Perception of High-Risk/Alert Medications, barriers, which factors may Discourage you from implementing High-Risk/Alert medications, and recommendations/suggestions for facilitating the implementation of High-Risk/Alert medicines. The 5-point Likert response scale system was used with closed-ended questions. The survey was validated through the revision of expert reviewers and pilot testing. Besides, various tests of reliability, McDonald{\textquoteright}s ω, Cronbach alpha, Gutmann{\textquoteright}s λ2, and Gutmann{\textquoteright}s λ6, were done with the study. In addition, the data analysis of the Perception of Pharmacists About the High-Risk/Alert Medications in Saudi Arabia is done through the survey monkey system. Besides, the statistical package of social sciences (SPSS), Jeffery{\textquoteright}s Amazing Statistics Program (JASP), and Microsoft Excel sheet version 16. Results: A total number of 442 pharmacists responded to the questionnaire. Of them, more than one-third responded from the Central region (183 (40.40\%)), and one Quarter responded from the Western part (119 (26.92\%)), with statistically significant differences between the provinces (p=0.000). Males responded more than females (264 (59.59\%)) versus 179 (40.41\%)), with statistically significant differences between all levels (p=0.000). Most of the responders were in the age group of 24-30 years (266 (59.91\%)) and 31-35 years (78 (17.57\%)), with statistically significant differences between all age groups (p=0.000). Most of the pharmacists were staff pharmacists (323 (72.75\%)) and pharmacy supervisors (56 (12.61\%)), with statistically significant differences between all levels (p=0.000). The average score of perception of pharmacists about High-Risk/Alert medications was (3.88). The element {\textquotedblleft}Staff compliance with protocols, guidelines and order sets related to high-alert medications is required{\textquotedblright} obtained the highest score (4.38). The pharmacists believe that Standard protocols, order sets, and orders express IV and neuraxial high-alert medication infusions/doses are highly recommended (4.36). The average score for the element {\textquotedblleft}Factors Discourage you to implement High-Risk/Alert medications{\textquotedblright} was (3.36). The highest score from the component {\textquotedblleft}The High-Risk/Alert medications are of a serious nature{\textquotedblright} was (3.92). The score for the element {\textquotedblleft}Lack of Periodic training of pharmacy staff about High-Risk/Alert medications {\textquotedblright} was (3.83), and {\textquotedblleft}Low level of clinical knowledge of High-Risk/Alert medications {\textquotedblleft}was (3.70). The most recommendations/suggestions for facilitating the implementation of High-Risk/ Alert medications were the Implementation of an electronic high-alert medications system 385(88.30\%), setup up the therapeutic protocol or guidelines for High-Risk/ Alert medications 347 (79.59\%), and standardizing the prescribing, preparation, dispensing and administration of High-Risk/Alert drugs 345 (79.13\%). Conclusion: The pharmacist attributed High-Risk/Alert medications as appropriate. Therefore, targeting periodic education and training. Besides, improving clinical knowledge and implementing an electronic High-Risk/Alert medications system are highly suggested to improve patient outcomes and avoid drug-related disorders at healthcare facilities in Saudi Arabia.

}, keywords = {Alert, Drugs., High-risk, Medications, Perception, Pharmacist}, doi = {10.5530/ijpcs.2022.11.22}, author = {Yousef Ahmed Alomi and Mohammad Abdulaziz AL-Tuwaijri and Nouf Saad Al-Saban and Maha Hussein Almadany and Faisal Safouq Alanazi} }